Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Revenue

Hualan Biological Vaccine had revenue of 26.78M CNY in the quarter ending March 31, 2026, with 10.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 7.79% year-over-year. In the year 2025, Hualan Biological Vaccine had annual revenue of 1.20B with 6.62% growth.

• Revenue (ttm): 1.20B
• Revenue Growth: +7.79%
• P/S Ratio: 10.46
• Revenue / Employee: 1.70M
• Employees: 708
• Market Cap: 12.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.20B	74.69M	6.62%
Dec 31, 2024	1.13B	-1.28B	-53.21%
Dec 31, 2023	2.41B	584.79M	32.03%
Jan 1, 2023	1.83B	-4.17M	-0.23%
Jan 1, 2022	1.83B	-596.52M	-24.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error